These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 29151154)

  • 21. Prolonged Inflation Technique Using a Scoring Balloon for Severe Calcified Lesion.
    Otsuka Y; Koyama T; Imoto Y; Katsuki Y; Kawahara M; Nakamura K; Kodama S; Noguchi H; Iwasaki K
    Int Heart J; 2017 Dec; 58(6):982-987. PubMed ID: 29162780
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coronary Artery Calcium and Long-Term Risk of Death, Myocardial Infarction, and Stroke: The Walter Reed Cohort Study.
    Mitchell JD; Paisley R; Moon P; Novak E; Villines TC
    JACC Cardiovasc Imaging; 2018 Dec; 11(12):1799-1806. PubMed ID: 29153576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New Insights into the Role of Visit-to-Visit Glycemic Variability and Blood Pressure Variability in Cardiovascular Disease Risk.
    Zhou JJ; Nuyujukian DS; Reaven PD
    Curr Cardiol Rep; 2021 Mar; 23(4):25. PubMed ID: 33655430
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of visit-to-visit blood pressure variability on cardiovascular events in populations with different body mass indexes: a prospective cohort study.
    Chen H; Chen Y; Wu W; Huang J; Chen Z; Chen Z; Yan X; Wu S
    BMJ Open; 2020 Sep; 10(9):e035836. PubMed ID: 32948548
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic importance of visit-to-visit blood pressure variability for micro- and macrovascular outcomes in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study.
    Cardoso CRL; Leite NC; Salles GF
    Cardiovasc Diabetol; 2020 May; 19(1):50. PubMed ID: 32359350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Visit-to-visit blood pressure variation and outcomes in heart failure with reduced ejection fraction: findings from the Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms trial.
    Monzo L; Ferreira JP; Abreu P; Szumski A; Böhm M; McMurray JJV; Pitt B; Swedberg K; van Veldhuisen DJ; Girerd N; Vincent J; Zannad F; Rossignol P
    J Hypertens; 2020 Mar; 38(3):420-425. PubMed ID: 31584516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estimating the association between blood pressure variability and cardiovascular disease: An application using the ARIC Study.
    Barrett JK; Huille R; Parker R; Yano Y; Griswold M
    Stat Med; 2019 May; 38(10):1855-1868. PubMed ID: 30575102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peak lung function during young adulthood and future long-term blood pressure variability: The Coronary Artery Risk Development in Young Adults (CARDIA) study.
    Tedla YG; Yano Y; Thyagarajan B; Kalhan R; Viera AJ; Rosenberg S; Greenland P; Carnethon MR
    Atherosclerosis; 2018 Aug; 275():225-231. PubMed ID: 29957459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Visit-To-Visit Blood Pressure Variability and the Risk of Dementia in Older People.
    van Middelaar T; van Dalen JW; van Gool WA; van den Born BH; van Vught LA; Moll van Charante EP; Richard E
    J Alzheimers Dis; 2018; 62(2):727-735. PubMed ID: 29480175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blood pressure variability and risk of cardiovascular events and death in patients with hypertension and different baseline risks.
    Mehlum MH; Liestøl K; Kjeldsen SE; Julius S; Hua TA; Rothwell PM; Mancia G; Parati G; Weber MA; Berge E
    Eur Heart J; 2018 Jun; 39(24):2243-2251. PubMed ID: 29365085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Visit-to-visit HbA1c variability and systolic blood pressure (SBP) variability are significantly and additively associated with mortality in individuals with type 1 diabetes: An observational study.
    Wightman SS; Sainsbury CAR; Jones GC
    Diabetes Obes Metab; 2018 Apr; 20(4):1014-1017. PubMed ID: 29266630
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Visit-to-visit variability of metabolic parameters and progression of atherosclerosis in computed tomography: follow up of an asymptomatic cohort.
    Lim YJ; Oh M; Park SG; Kim H; Yoo S
    Cardiovasc Diagn Ther; 2023 Oct; 13(5):855-865. PubMed ID: 37941833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Visit-to-visit blood pressure variability and mortality and cardiovascular outcomes after acute myocardial infarction.
    Choo EH; Mok JS; Chung WB; Lim S; Choi IJ; Lee KY; Hwang BH; Kim CJ; Park MW; Lee JM; Park CS; Kim HY; Yoo KD; Jeon DS; Youn HJ; Chung WS; Kim MC; Jeong MH; Yim HW; Ahn Y; Chang K
    J Hum Hypertens; 2022 Nov; 36(11):960-967. PubMed ID: 34518618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Visit-to-visit variability of blood pressure and cardiovascular events among the working-age population in Japan: findings from the Japan Epidemiology Collaboration on Occupational Health Study.
    Inoue Y; Kuwahara K; Hu H; Yamamoto S; Nakagawa T; Honda T; Eguchi M; Kochi T; Okazaki H; Miyamoto T; Shimizu M; Ogasawara T; Sasaki N; Uehara A; Yamamoto M; Tomita K; Hori A; Nagahama S; Kabe I; Mizoue T; Dohi S;
    Hypertens Res; 2021 Aug; 44(8):1017-1025. PubMed ID: 33990791
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of Variability in Blood Pressure, Glucose and Cholesterol Concentrations, and Body Weight on Emergency Hospitalization and 30-Day Mortality in the General Population.
    Lee SH; Han K; Kwon HS; Yoon KH; Kim MK
    J Am Heart Assoc; 2020 Nov; 9(22):e017475. PubMed ID: 33153393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of Cardiovascular Risk Factor Variability on Health Outcomes.
    Lee SH; Kim MK; Rhee EJ
    Endocrinol Metab (Seoul); 2020 Jun; 35(2):217-226. PubMed ID: 32615706
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Visit-to-visit variability of systolic blood pressure predicts all-cause mortality in patients received percutaneous coronary intervention with drug-eluting stents.
    Seo SM; Chung WB; Choi IJ; Koh YS; Ihm SH; Kim PJ; Chung WS; Seung KB
    Heart Vessels; 2018 May; 33(5):489-497. PubMed ID: 29151154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term prognostic implications of visit-to-visit blood pressure variability in patients with ischemic stroke.
    Lau KK; Wong YK; Teo KC; Chang RS; Chan KH; Hon SF; Wat KL; Cheung RT; Li LS; Siu CW; Tse HF
    Am J Hypertens; 2014 Dec; 27(12):1486-94. PubMed ID: 24842389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
    Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1242-9. PubMed ID: 24355114
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differences in ward-to-cath lab systolic blood pressure predicts long-term adverse outcomes after drug-eluting stent implantation.
    Her AY; Ann SH; Lee JH; Kim JM; Kim YH; Garg S; Singh GB; Shin ES
    Heart Vessels; 2015 Nov; 30(6):740-5. PubMed ID: 25062712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.